Rituximab, Ara-C, Dexamethasone and Oxaliplatin Is Safe and Active in Heavily Pretreated Patients with Diffuse Large B-Cell Lymphoma

Publisher： Karger

E-ISSN： 1423-0232|69|6|499-502

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.6, 2006-02, pp. : 499-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Herpesviridae Viral Infections following Rituximab Combined Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-02 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Yttrium-90 Ibritumomab Tiuxetan Followed by Rituximab Maintenance as Treatment for Patients with Diffuse Large B-Cell Lymphoma Are Not Candidates for Autologous Stem Cell Transplant

By  

Acta Haematologica, Vol. 133, Iss. 4, 2015-02 ,pp. : 347-353

Karger

Access to resources Recommend Favorite

Do Hepatitis C Virus Genotypes Influence Liver Dysfunction following Rituximab-Containing Regimens in Patients with Diffuse Large B Cell Lymphoma?

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-02 ,pp. : 178-181

Karger

Access to resources Recommend Favorite

Rituximab maintenance improves survival in male patients with diffuse large B‐cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 710-719

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 654-662

John Wiley & Sons Inc

Access to resources Recommend Favorite